电针通过Nrf2通路抑制铁死亡缓解小鼠子宫内膜异位症
本研究在小鼠子宫内膜异位症模型中探讨腹膜铁过载是否通过Nrf2通路功能障碍及铁死亡驱动纤维化,并评估电针干预效果。结果显示在位与异位内膜均存在显著纤维化和铁死亡,Nrf2通路失活且核转位受损,电针可抑制病灶生长、减轻纤维化和铁死亡并逆转Nrf2核转位障碍。
要点
- 子宫内膜异位症小鼠在位与异位内膜均出现显著纤维化和铁死亡(P<0.01)。
- Nrf2通路功能性失活伴核转位受损(P<0.01),在位内膜中不依赖Keap1。
- 电针抑制病灶生长(P<0.05)、减轻纤维化和铁死亡(P<0.01)并逆转Nrf2核转位障碍(P<0.01)。
核心结论
- 首次系统证明「Nrf2通路失活—铁死亡—纤维化」轴在子宫内膜异位症尤其在位内膜中的关键作用。
- 电针通过靶向该通路发挥治疗作用,为其临床应用提供实验基础。
研究设计与样本
- 建立小鼠子宫内膜异位症模型:腹腔注射同系子宫碎片联合周期性全血注射,并给予电针干预。
- 采用组织学染色、分子生物学技术和生化分析系统评估纤维化、铁死亡相关标志物、Nrf2/Keap1通路活性、腹膜微环境及全身病理指标。
主要发现
- 子宫内膜异位症小鼠在位子宫和异位病灶均有显著纤维化(P<0.01)并伴明显铁死亡(P<0.01)。
- 这些组织中Nrf2通路功能性失活,核转位受损(P<0.01)。
- 在位子宫中该抑制不依赖经典调控蛋白Keap1,提示Nrf2存在替代调控机制。
- 电针治疗有效抑制病灶生长(P<0.05)、减轻纤维化(P<0.01)和铁死亡(P<0.01)。
- 电针特异性逆转Nrf2核转位障碍(P<0.01),并改善全身炎症和内分泌紊乱。
临床怎么用
- 提示电针可能作为靶向Nrf2通路抑制铁死亡和纤维化的潜在治疗策略。
- 为子宫内膜异位症尤其在位内膜病变的病理机制理解提供新视角。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does peritoneal iron overload drive fibrosis in endometriosis through Nrf2 pathway dysfunction and the resulting ferroptosis, and can electroacupuncture intervene in this process? DESIGN: An endometriosis mouse model was established by intraperitoneal injection of syngeneic uterine fragments combined with periodic injection of whole blood, and subjected to electroacupuncture intervention. Fibrosis, ferroptosis-related markers, Nrf2/Keap1 pathway activity, the peritoneal microenvironment and systemic pathological indicators were systematically assessed using histological staining, molecular biology techniques and biochemical analyses. RESULTS: Eutopic uterus and ectopic lesions in mice with endometriosis had significant fibrosis (P < 0.01) accompanied by pronounced ferroptosis (P < 0.01). Mechanistically, the Nrf2 pathway was functionally inactivated in these tissues, with impaired nuclear translocation (P < 0.01). Notably, in the eutopic uterus, this inhibition occurred independently of its classical regulatory protein Keap1, suggesting alternative regulatory mechanisms for Nrf2. Electroacupuncture treatment effectively suppressed lesion growth (P < 0.05) alleviated fibrosis (P < 0.01) and ferroptosis (P < 0.01), and also specifically reversed the impairment of Nrf2 nuclear translocation (P < 0.01) and improved systemic inflammation and endocrine disturbances. CONCLUSIONS: To our knowledge, this study is the first to systematically demonstrate the pivotal role of the 'Nrf2 pathway inactivation‒ferroptosis‒fibrosis' axis in endometriosis, particularly in the eutopic uterus. Our findings provide a novel paradigm for understanding the pathological mechanisms of endometriosis and confirms that electroacupuncture exerts therapeutic effects by targeting this pathway, offering a solid experimental foundation for its clinical application.
引用
- Zan Y, Zhuang Y, Zhu Q, et al. Electroacupuncture alleviates endometriosis by suppressing ferroptosis in murine ectopic and eutopic endometria via the Nrf2 pathway. Reprod Biomed Online. 2026. PMID: 42155249. doi:10.1016/j.rbmo.2026.105633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。